sglt2 inhibitor glp 1 agonist combination Cardiorenal Protection: Potential of Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy Combining GLP-1 Receptor Agonists and
Description
It is about preserving what you have while the body shifts to burning fat for fuel

Contaminated vials can cause injection site infections and render expensive peptides useless
In diet-induced obese mice showing MASLD, the principal component analysis demonstrated that the combination of SGLT2i and GLP1-RA showed more potent beneficial effects on MASLD than SGLT2i and dipeptidyl peptidase-4 inhibitor 17

Salvad L, Palomer X, Barroso E, Vzquez-Carrera M

However, as this was an observational target trial emulation conducted in a predominantly male Veterans Affairs population, the results support but do not establish causality and may have limited generalisability to broader populations, particularly women and non-veteran groups
